Group One Trading’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3 Buy
+1
New +$6 ﹤0.01% 7435
2026
Q2
– Hold
0
– – – 7468
2026
Q1
– Hold
0
– – – 7485
2025
Q4
– Hold
0
– – – 7970
2025
Q3
– Hold
0
– – – 8286
2025
Q2
– Hold
0
– – – 7832
2025
Q1
– Hold
0
– – – 7438
2024
Q4
– Hold
0
– – – 7101
2024
Q3
– Sell
-1
Closed -$1.24K – 6503
2024
Q2
$1.56K Hold
1
– – ﹤0.01% 6269
2024
Q1
$2.47K Hold
1
– – ﹤0.01% 6442
2023
Q4
$7.6K Buy
+1
New +$11.5K ﹤0.01% 6333
2023
Q3
– Sell
-1
Closed -$27.6K – 7136
2023
Q2
$30.8K Sell
1
-1
-50% -$37.2K ﹤0.01% 5661
2023
Q1
$95.6K Buy
2
+1
+100% +$56.4K ﹤0.01% 4339
2022
Q4
$87.5K Sell
1
-2
-67% -$113K ﹤0.01% 4547
2022
Q3
$197K Sell
3
-1
-25% -$70K ﹤0.01% 4159
2022
Q2
$219K Sell
4
-1
-20% -$70.4K ﹤0.01% 4214
2022
Q1
$485K Buy
5
+1
+25% +$97.5K ﹤0.01% 3853
2021
Q4
$242K Buy
4
+2
+100% +$167K ﹤0.01% 4905
2021
Q3
$263K Buy
+2
New +$259K ﹤0.01% 4897
2021
Q2
– Hold
0
– – – 8295
2021
Q1
– Hold
0
– – – 5842

Other funds holding GNPX

Group One Trading's GNPX Position: Q3 2026 in Review

Group One Trading opened a new position in Genprex (GNPX) in Q3 2026: 1 share worth $3. The stake represents ﹤0.01% of the portfolio and ranks #7435 among its holdings. This is a return to the name: Group One Trading previously reported a position in GNPX as recently as Q2 2024.

Group One Trading first reported a position in GNPX in Q3 2021 and has held it in 12 quarters since. The position peaked at $485K in Q1 2022. 16 funds tracked by Wall St. Rank hold GNPX as of Q3 2026.

  • Group One Trading held 1 share of Genprex worth $3 as of Q3 2026.
  • Genprex was a new Group One Trading position in Q3 2026.
  • Genprex made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7435 holding.
  • Group One Trading first reported a position in Genprex in Q3 2021 and has held it in 12 quarters since.
  • Group One Trading's Genprex position peaked at $485K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Genprex as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.